Safety and Tolerability of Anti-microRNA-328 Ophthalmic Solution, SHJ002, in Pediatric Subjects: First-in-Human Clinical Study.

Saved in:
Bibliographic Details
Title: Safety and Tolerability of Anti-microRNA-328 Ophthalmic Solution, SHJ002, in Pediatric Subjects: First-in-Human Clinical Study.
Authors: Chen JL; Department of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; Center for General Education, Cheng Shiu University, Kaohsiung, Taiwan., Lai WY; Department of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan., Lin RT; Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan., Juo SH; Department of Medical Research, China Medical University Hospital, Taichung, Taiwan; Institute of Translational Medicine and New Drug Development, China Medical University, Taichung, Taiwan; Drug Development Center, China Medical University, Taichung, Taiwan; Sunhawk Vision Biotech, Inc, Kaohsiung, Taiwan., Liang CL; Sunhawk Vision Biotech, Inc, Kaohsiung, Taiwan; Bright Eyes Clinic, Kaohsiung, Taiwan. Electronic address: eyedoctorliang@shvbiotech.com.
Source: Clinical therapeutics [Clin Ther] 2024 Oct; Vol. 46 (10), pp. 768-772. Date of Electronic Publication: 2024 Sep 07.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Excerpta Medica Country of Publication: United States NLM ID: 7706726 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-114X (Electronic) Linking ISSN: 01492918 NLM ISO Abbreviation: Clin Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-114X
DOI:10.1016/j.clinthera.2024.08.015